NVS logo

NVS
Novartis AG

6,848
Mkt Cap
$278.65B
Volume
839,826.00
52W High
$170.46
52W Low
$97.72
PE Ratio
20.18
NVS Fundamentals
Price
$147.57
Prev Close
$146.03
Open
$147.32
50D MA
$154.83
Beta
0.27
Avg. Volume
2.92M
EPS (Annual)
$7.25
P/B
6.04
Rev/Employee
$728,224.22
$293,740.89
Loading...
Loading...
News
all
press releases
CWA Asset Management Group LLC Increases Holdings in Novartis AG $NVS
CWA Asset Management Group LLC raised its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 151.9% during the fourth quarter, according to its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Novartis (NYSE:NVS) Upgraded at Sanford C. Bernstein
Sanford C. Bernstein upgraded shares of Novartis to a "hold" rating in a report on Thursday...
MarketBeat·2d ago
News Placeholder
Novartis AG (NYSE:NVS) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Novartis AG (NYSE:NVS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the sixteen research firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, six have given a hold rating, six...
MarketBeat·2d ago
News Placeholder
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term pipeline growth.
Zacks·3d ago
News Placeholder
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug declines.
Zacks·3d ago
News Placeholder
Wilmington Savings Fund Society FSB Sells 26,716 Shares of Novartis AG $NVS
Wilmington Savings Fund Society FSB trimmed its holdings in Novartis AG (NYSE:NVS - Free Report) by 64.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,527 shares of the company's stock after selling 26,716 shares duri...
MarketBeat·3d ago
News Placeholder
Novartis AG $NVS Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its stake in Novartis AG (NYSE:NVS - Free Report) by 18.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 537,543 shares of the company's stock after acquiring an addit...
MarketBeat·4d ago
News Placeholder
Novartis AG $NVS Shares Acquired by CIBC Private Wealth Group LLC
CIBC Private Wealth Group LLC boosted its stake in Novartis AG (NYSE:NVS - Free Report) by 3.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 495,791 shares of the company's stock after buying an additional...
MarketBeat·4d ago
News Placeholder
Novartis AG $NVS Shares Sold by Greenfield Seitz Capital Management LLC
Greenfield Seitz Capital Management LLC cut its holdings in Novartis AG (NYSE:NVS - Free Report) by 18.2% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·5d ago
News Placeholder
CIBC Bancorp USA Inc. Takes Position in Novartis AG $NVS
CIBC Bancorp USA Inc. purchased a new position in Novartis AG (NYSE:NVS - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange...
MarketBeat·5d ago
<
1
2
...
>

Latest NVS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.